Bipartisan support grows for psychedelic medicine, but hurdles remain

Psychedelic drugs like psilocybin and MDMA are gaining bipartisan support in Washington as potential treatments for mental health issues like PTSD, anxiety, and depression. But concerns about side effects persist. Host Kelly Hooper talks with POLITICO health care reporter Katherine Ellen Foley about the promising yet delicate path forward for psychedelic therapies.     Learn more about your ad choices. Visit megaphone.fm/adchoices